DIN EN ISO 13485:2016
COVID-19 Real-Time PCR
COVID-19 FluoGene® Q
SARS-CoV-2 is a novel coronavirus causing the coronavirus disease 2019 (COVID-19). It is closely related to the SARS virus and was first identified in December 2019 in Wuhan, China. By now it has spread globally resulting in an ongoing pandemic.
COVID-19 FluoGene® Q kit is a CE-IVD marked dual-target multiplex qRT-PCR for the qualitative detection of severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific RNA. The system works with any RNA isolation method, but ideally it is combined with automated viral DNA/RNA extraction consisting of the BEXS 12 instrument and the BEXS 12 Ready Viral DNA/RNA Bead Kit .
The isolated RNA target is transcribed into cDNA and the target genes are amplified in a single step qRT-PCR. The primer probe mixes detect the SARS-CoV-2 specific genes M and N1, as well as the human RNase P gene as an internal control reaction. A positive control is included in the test system. The kit is validated on the FluoQube, QTower, ABI7500 and the QuantStudio 6 Pro.
As of March 2022, the kit now contains specific detection of Omikron subtypes BA.1 and BA.2.
The advantages of the COVID-19 FluoGene® Q
qRT-PCR
Detection of SARS-CoV-2 genes: M and N1
Detection of internal control human RNasePgene in each well
Validated in combination mit with BEXS 12 automatisated RNA Extraction
Validated on FluoQube, QTower, ABI7500 & Quantstudio 6 Pro
CE IVD
Detects all mutations known so far (as of 10.03.2022)
Detection of SARS-CoV-2 via additive E & N1 gene PCR in the FAM channel
Since March 2022:
• Positive controls specific to BA.1 or BA.2 included
Download
Instruction: COVID-19 FluoGene® Q
COVID-19 FluoGene® Q
| Item number | Name | Test / Plate |
|---|---|---|
| 003 COV 096 | COVID-19 FluoGene Q | 96 Tests/Kit |
| 003 COV 960 | COVID-19 FluoGene Q | 960 Tests/Kit |
| 003 COV 500 | COVID-19 FluoGene Q | 500 Tests/Kit |
